Melioidosis is a severe infectious disease of animals and humans caused by the Gram-negative intracellular pathogen Burkholderia pseudomallei. An Inv/Mxi-Spa-like type III protein secretion apparatus, encoded by the B. pseudomallei bsa locus, facilitates bacterial invasion of epithelial cells, escape from endocytic vesicles and intracellular survival. This study investigated the role of the Bsa type III secretion system in the pathogenesis of melioidosis in murine models. B. pseudomallei bipD mutants, lacking a component of the translocation apparatus, were found to be significantly attenuated following intraperitoneal or intranasal challenge of BALB/c mice. Furthermore, a bipD mutant was attenuated in C57BL/6 IL-12 p40−/− mice, which are highly susceptible to B. pseudomallei infection. Mutation of bipD impaired bacterial replication in the liver and spleen of BALB/c mice in the early stages of infection. B. pseudomallei mutants lacking either the type III secreted guanine nucleotide exchange factor BopE or the putative effectors BopA or BopB exhibited varying degrees of attenuation, with mutations in bopA and bopB causing a significant delay in median time to death. This indicates that bsa-encoded type III secreted proteins may act in concert to determine the outcome of B. pseudomallei infection in mice. Mice inoculated with the B. pseudomallei bipD mutant were partially protected against subsequent challenge with wild-type B. pseudomallei. However, immunization of mice with purified BipD protein was not protective.
AllaouiA., MounierJ., PrevostM. C., SansonettiP. J., ParsotC.1992; icsB: a Shigella flexneri virulence gene necessary for the lysis of protrusions during intercellular spread. Mol Microbiol 6:1605–1616[CrossRef]
AtkinsT., PriorR. G., MackK., RussellP., NelsonM., OystonP. C., DouganG., TitballR. W.2002a; A mutant of Burkholderia pseudomallei, auxotrophic in the branched chain amino acid biosynthetic pathway, is attenuated and protective in a murine model of melioidosis. Infect Immun 70:5290–5294[CrossRef]
AtkinsT., PriorR., MackK.7 other authors2002b; Characterisation of an acapsular mutant of Burkholderia pseudomallei identified by signature tagged mutagenesis. J Med Microbiol 51:539–547
BisphamJ., TripathiB. N., WatsonP. R., WallisT. S.2001; Salmonella pathogenicity island 2 influences both systemic salmonellosis and Salmonella-induced enteritis in calves. Infect Immun 69:367–377[CrossRef]
CollazoC. M., GalánJ. E.1997; The invasion-associated type III system of Salmonella typhimurium directs the translocation of Sip proteins into the host cell. Mol Microbiol 24:747–756[CrossRef]
KanigaK., TrollingerD., GalánJ. E.1995; Identification of two targets of the type III protein secretion system encoded by the inv and spa loci of Salmonella typhimurium that have homology to the Shigella IpaD and IpaA proteins. J Bacteriol 177:7078–7085
LearyS. E., WilliamsonE. D., GriffinK. F., RussellP., EleyS. M., TitballR. W.1995; Active immunisation with recombinant V antigen from Yersinia pestis protects mice against plague. Infect Immun 63:2854–2858
NorrisF. A., WilsonM. P., WallisT. S., GalyovE. E., MajerusP. W.1998; SopB, a protein required for virulence of Salmonella dublin, is an inositol phosphatase. Proc Natl Acad Sci U S A 95:14057–14059[CrossRef]
RainbowL., HartC. A., WinstanleyC.2002; Distribution of type III secretion gene clusters in Burkholderia pseudomallei, B. thailandensis and B. mallei. J Med Microbiol 51:374–384
SansonettiP. J.2001; Rupture, invasion and inflammatory destruction of the intestinal barrier by Shigella, making sense of prokaryote-eukaryote cross-talks. FEMS Microbiol Rev 25:3–14
SantanirandP., HarleyV. S., DanceD. A., DrasarB. S., BancroftG. J.1999; Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei. Infect Immun 67:3593–3600
SawaT., YahrT. L., OharaM., KurahashiK., GropperM. A., Wiener-KronishJ. P., FrankD. W.1999; Active and passive immunisation with the Pseudomonas V antigen protects against type III intoxication and lung injury. Nat Med 5:392–398[CrossRef]
SimonR., PreiferU., PuhlerA.1983; A broad host range mobilisation system for in vivo genetic engineering: transposon mutagenesis in Gram-negative bacteria. Bio/Technology 1:784–791[CrossRef]
StevensM. P., WoodM. W., TaylorL. A., MonaghanP., HawesP., JonesP. W., WallisT. S., GalyovE. E.2002; An Inv/Mxi-Spa-like type III protein secretion system in Burkholderia pseudomallei modulates intracellular behaviour of the pathogen. Mol Microbiol 46:649–659[CrossRef]
TomichM., GriffithA., HerfstC. A., BurnsJ. L., MohrC. D.2003; Attenuated virulence of a Burkholderia cepacia type III secretion mutant in a murine model of infection. Infect Immun 71:1405–1415[CrossRef]
UlrichR. L., DeShazerD.2004; Type III secretion: a virulence factor delivery system essential for the pathogenicity of Burkholderia mallei. Infect Immun 72:1150–1154[CrossRef]
WinstanleyC., HalesB. A., HartC. A.1999; Evidence for the presence in Burkholderia pseudomallei of a type III secretion system-associated gene cluster. J Med Microbiol 48:649–656[CrossRef]
ZhouD., ChenL. M., HernandezL., ShearsS. B., GalánJ. E.2001; A Salmonella inositol polyphosphatase acts in conjunction with other bacterial effectors to promote host cell actin cytoskeleton rearrangements and bacterial internalization. Mol Microbiol 39:248–259[CrossRef]